If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMADE.L Regulatory News (MADE)

  • There is currently no data for MADE

Form 8. (EPT/RI) - Mae.com Group plc

17 Oct 2022 11:34

RNS Number : 1092D JPMorgan Securities Plc 17 October 2022 160

FORM 8. (EPT/RI)

160

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8. of the Takeover Coe (the "Coe")

160

1.160160160160160160160160 KEY INFORMATION

160

(a) Name of exempt principal traer:

J.P. Morgan Securities Plc

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

160160160160 Use a separate form for each offeror/offeree

Mae.com Group plc

(c) Name of the party to the offer with which exempt principal traer is connecte:

Corporate Broker to Mae.com Group plc

() Date ealing unertaken:

14 October 2022

(e) In aition to the company in 1(b) above, is the exempt principal traer making isclosures in respect of any other party to this offer?

160160160160 If it is a cash offer or possible cash offer, state "N/A"

N/A

160

2.160160160160160160160160 DEALINGS BY THE EXEMPT PRINCIPAL TRADER

160

Where there have been ealings in more than one class of relevant securities of the offeror or offeree name in 1(b), copy table 2(a), (b), (c) or () (as appropriate) for each aitional class of relevant security ealt in.

160

The currency of all prices an other monetary amounts shoul be state.

160

(a)160160160160160160160 Purchases an sales

160

Class of relevant security

Purchases/ sales

160

Total number of securities

Highest price per unit pai/receive

Lowest price per unit pai/receive

0.01p orinary

Purchase

160

Sale

27,333

160

90,000

0.0624 GBP

160

0.0702 GBP

0.0624 GBP

160

0.0636 GBP

160

(b)160160160160160160160 Cash-settle erivative transactions

160

Class of relevant security

Prouct escription

e.g. CFD

Nature of ealing

e.g. opening/closing a long/short position, increasing/reucing a long/short position

Number of reference securities

Price per unit

160

160

160

160

(c)160160160160160160160 Stock-settle erivative transactions (incluing options)

160

(i)160160160160160160160160 Writing, selling, purchasing or varying

160

Class of relevant security

Prouct escription e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry ate

Option money pai/ receive per unit

160

(ii)160160160160160160160 Exercise

160

Class of relevant security

Prouct escription

e.g. call option

Exercising/ exercise against

Number of securities

Exercise price per unit

160

160

160

160

160

160

160

()160160160160160160160 Other ealings (incluing subscribing for new securities)

160

Class of relevant security

Nature of ealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

160

160

160

160

160

160

3.160160160160160160160160 OTHER INFORMATION

160

(a)160160160160160160160 Inemnity an other ealing arrangements

160

Details of any inemnity or option arrangement, or any agreement or unerstaning, formal or informal, relating to relevant securities which may be an inucement to eal or refrain from ealing entere into by the exempt principal traer making the isclosure an any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments an letters of intent shoul not be inclue.160 If there are no such agreements, arrangements or unerstanings, state "none"

None

160

160

160

(b)160160160160160160160 Agreements, arrangements or unerstanings relating to options or erivatives

160

Details of any agreement, arrangement or unerstaning, formal or informal, between the exempt principal traer making the isclosure an any other person relating to:

(i)160 the voting rights of any relevant securities uner any option or

(ii) the voting rights or future acquisition or isposal of any relevant securities to which any erivative is reference:

If there are no such agreements, arrangements or unerstanings, state "none"

None

160

160

160

Date of isclosure:

17 October 2022

Contact name:

Alwyn Basch

Telephone number:

020 7742 7407

160

Public isclosures uner Rule 8 of the Coe must be mae to a Regulatory Information Service.160

160

The Panel's Market Surveillance Unit is available for consultation in relation to the Coe's ealing isclosure requirements on +44 (0)20 7638 0129.

160

The Coe can be viewe on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provie by RNS, the news service of the Lonon Stock Exchange. RNS is approve by the Financial Conuct Authority to act as a Primary Information Provier in the Unite Kingom. Terms an conitions relating to the use an istribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP aress to confirm compliance with the terms an conitions, to analyse how you engage with the information containe in this communication, an to share such analysis on an anonymise basis with others as part of our commercial services. For further information about how RNS an the Lonon Stock Exchange use the personal ata you provie us, please see our Privacy Policy.160 END160160FERFIFEAISLDLIF
Date   Source Headline
21st Jun 202212:41 pmRNSBlock Listing Application
16th May 20227:01 amRNSDirectorate Change
16th May 20227:00 amRNSTrading Update
9th May 20227:00 amRNSAcquisition
5th May 20224:23 pmRNSResult of AGM
5th May 20228:30 amRNSDirectorate Change
11th Apr 202211:59 amRNSHolding(s) in Company
6th Apr 202212:43 pmRNSDirector/PDMR Shareholding
1st Apr 202212:25 pmRNSNotice of AGM
25th Mar 20227:00 amRNSDirectorate Change
17th Mar 202211:26 amRNSAnnual Financial Report
8th Mar 20227:00 amRNSPreliminary Results
28th Feb 202211:26 amRNSTotal Voting Rights
21st Feb 20227:00 amRNSDirectorate Change
31st Jan 202210:17 amRNSTotal Voting Rights
6th Jan 20227:00 amRNSTrading Statement
31st Dec 20219:38 amRNSTotal Voting Rights
21st Dec 202110:31 amRNSBlock listing Interim Review
15th Dec 20213:31 pmRNSCompletion of Capital Reduction
9th Dec 20217:00 amRNSTrading Update
30th Nov 202111:01 amRNSTotal Voting Rights
29th Oct 202110:08 amRNSTotal Voting Rights
30th Sep 202110:07 amRNSTotal Voting Rights
14th Sep 20217:00 amRNSInterim Results for the six months to 30 June 2021
31st Aug 202110:42 amRNSTotal Voting Rights
3rd Aug 20215:01 pmRNSHolding(s) in Company
30th Jul 202111:21 amRNSTotal Voting Rights
30th Jul 20217:00 amRNSNotice of Half Year Results
30th Jul 20217:00 amRNSAppointment of Joint Corporate Brokers
23rd Jul 20212:46 pmRNSHolding(s) in Company
23rd Jul 20211:47 pmRNSHolding(s) in Company
16th Jul 20217:00 amRNSStabilisation Notice
16th Jul 20217:00 amRNSExercise of Over-allotment Option
14th Jul 20217:00 amRNSStabilisation Notice
13th Jul 20214:17 pmRNSDirector/PDMR Shareholding
7th Jul 20217:00 amRNSStabilisation Notice
1st Jul 202112:10 pmRNSHolding(s) in Company
1st Jul 202112:08 pmRNSHolding(s) in Company
30th Jun 202112:10 pmRNSTotal Voting Rights
30th Jun 20217:00 amRNSStabilisation Notice
24th Jun 202110:58 amRNSHolding(s) in Company
24th Jun 202110:47 amRNSDirector/PDMR Shareholding - Correction
23rd Jun 20212:35 pmRNSHolding(s) in Company
23rd Jun 20217:00 amRNSStabilisation Notice
21st Jun 202110:21 amRNSDirector/PDMR Shareholding
21st Jun 202110:15 amRNSHolding(s) in Company
21st Jun 20218:00 amRNSAdmission to Trading
17th Jun 202111:03 amRNSBlock Listing Application
16th Jun 20211:26 pmRNSApproval and Publication of Prospectus

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.